Evogene Ltd.
EVGN
$1.06
$0.010.47%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 105.60% | -40.80% | -40.28% | -65.69% | 43.27% |
| Total Depreciation and Amortization | 183.73% | 248.33% | -91.06% | 0.30% | 2.16% |
| Total Amortization of Deferred Charges | 143.80% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -378.38% | 968.95% | -124.68% | -208.87% | 105.43% |
| Change in Net Operating Assets | -25.73% | -394.08% | 107.90% | 138.71% | -248.39% |
| Cash from Operations | 6.62% | -2.22% | -32.73% | -37.25% | 15.20% |
| Capital Expenditure | -135.04% | -448.00% | 82.27% | 60.19% | -74.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 321.54% | -33.42% | 176.46% | -112.95% | 149.64% |
| Cash from Investing | 334.21% | -37.17% | 173.59% | -116.08% | 146.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -94.34% | 55.65% | -3.46% | -0.47% | -1.93% |
| Issuance of Common Stock | -88.33% | 6,571.08% | 2,666.67% | -99.44% | 11,764.71% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -1,100.00% | 103.60% | 134.48% | -100.55% |
| Cash from Financing | -91.82% | 3,663.58% | 58.86% | -101.88% | -25.35% |
| Foreign Exchange rate Adjustments | -163.64% | 131.43% | -94.44% | 453.57% | 87.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.35% | 175.40% | 72.55% | -192.41% | 356.52% |